Latest News

The centre plans to shake up approaches to clinical trial design and delivery by developing pioneering new ways to speed up the process and drive improvements in treatment and recovery.
A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.